Subjects were divided into three groups receiving, respectively, rosiglitazone and metformin, rosiglitazone and losartan, or rosiglitazone alone for 48 weeks
Course Format Homestudy Course Syllabus Introduction Semaglutide, Iiraglutide, and Tirzepatide Mechanism of Action Effectiveness of GLP-1 and GIP/GLP-1 RAs for Weight Loss Comparison of Drug Effectiveness Causes of GLP-1 AND GLP/GIP Receptor Failure Common and Mild Adverse Effects Significant Adverse Effects Clinical Considerations for Obesity Treatment Benefits and Risks Choosing the Correct Treatment Lifestyle Changes Duration of Therapy Adverse Effect Monitoring Patient Education Case Study: GLP-1 With Insulin Treatment for Diabetes Summary Author Dana Bartlett, RN, BSN, MSN, MA, CSPI Dana Bartlett is a professional nurse and author
The ultimate goal is to give readers the knowledge they need to make informed decisions about their weight loss journey
The analysis included older weight loss drugs as well as newer GLP-1 drugs, including Wegovy (semaglutide) and Zepbound (tirzepatide)
[PUBMED Abstract] Berwick M, MacArthur J, Orlow I, et al.: MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors
A 4.5 on Trustpilot with a false-review warning, an F from the BBB, and genuinely split Reddit feedback dont paint a clear picture
